SE8200252L - Farmaceutisk komposition - Google Patents

Farmaceutisk komposition

Info

Publication number
SE8200252L
SE8200252L SE8200252A SE8200252A SE8200252L SE 8200252 L SE8200252 L SE 8200252L SE 8200252 A SE8200252 A SE 8200252A SE 8200252 A SE8200252 A SE 8200252A SE 8200252 L SE8200252 L SE 8200252L
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
water
physiologically acceptable
soluble salt
acid
Prior art date
Application number
SE8200252A
Other languages
English (en)
Inventor
J-L Hultman
G Ronquist
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE8200252A priority Critical patent/SE8200252L/sv
Priority to ZA83130A priority patent/ZA83130B/xx
Priority to AU11058/83A priority patent/AU1105883A/en
Priority to PCT/SE1983/000003 priority patent/WO1983002391A1/en
Priority to EP83850004A priority patent/EP0085033A1/en
Priority to EP83900363A priority patent/EP0098853A1/en
Priority to JP83500392A priority patent/JPS58502208A/ja
Publication of SE8200252L publication Critical patent/SE8200252L/sv
Priority to NO833257A priority patent/NO833257L/no
Priority to DK4212/83A priority patent/DK421283D0/da
Priority to FI833320A priority patent/FI833320A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE8200252A 1982-01-18 1982-01-18 Farmaceutisk komposition SE8200252L (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE8200252A SE8200252L (sv) 1982-01-18 1982-01-18 Farmaceutisk komposition
ZA83130A ZA83130B (en) 1982-01-18 1983-01-10 A pharmaceutical composition
AU11058/83A AU1105883A (en) 1982-01-18 1983-01-14 A pharmaceutical composition
PCT/SE1983/000003 WO1983002391A1 (en) 1982-01-18 1983-01-14 A pharmaceutical composition for preventing and treating ischemic cell damage and methods for the use and preparation thereof
EP83850004A EP0085033A1 (en) 1982-01-18 1983-01-14 A pharmaceutical composition
EP83900363A EP0098853A1 (en) 1982-01-18 1983-01-14 A pharmaceutical composition for preventing and treating ischemic cell damage and methods for the use and preparation thereof
JP83500392A JPS58502208A (ja) 1982-01-18 1983-01-14 薬学的組成物
NO833257A NO833257L (no) 1982-01-18 1983-09-12 Farmasoeytisk preparat for hindring og behandling av ischemisk celleskade og fremgangsmaater for bruk og fremstilling derav
DK4212/83A DK421283D0 (da) 1982-01-18 1983-09-15 Farmaceutisk praeparat til forebyggelse og behandling af ischaemisk cellelaesion og fremgangsmade til fremstilling deraf
FI833320A FI833320A (fi) 1982-01-18 1983-09-16 Foerfarande foer foerhindrande och behandling av pao lokal blodbrist beroende cellskador samt foerfaranden foer anvaendning och framstaellning daerav

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8200252A SE8200252L (sv) 1982-01-18 1982-01-18 Farmaceutisk komposition

Publications (1)

Publication Number Publication Date
SE8200252L true SE8200252L (sv) 1983-07-19

Family

ID=20345754

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8200252A SE8200252L (sv) 1982-01-18 1982-01-18 Farmaceutisk komposition

Country Status (8)

Country Link
EP (2) EP0085033A1 (sv)
JP (1) JPS58502208A (sv)
DK (1) DK421283D0 (sv)
FI (1) FI833320A (sv)
NO (1) NO833257L (sv)
SE (1) SE8200252L (sv)
WO (1) WO1983002391A1 (sv)
ZA (1) ZA83130B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8403912D0 (sv) * 1984-07-30 1984-07-30 Pharmacia Ab Lekemedelssats eller -komposition
US4874882A (en) * 1986-03-25 1989-10-17 Ube Industries, Ltd. Process for preparing monosodium phosphoenolpyruvate
WO1988002258A1 (en) * 1986-10-06 1988-04-07 The University Of Virginia Alumni Patents Foundati Use of an adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
JP2770175B2 (ja) * 1988-09-27 1998-06-25 科学技術振興事業団 腎臓の庇護液
JP2914454B2 (ja) * 1989-03-29 1999-06-28 メドコー・リサーチ・インコーポレイテッド 血管診断助剤
FR2684381B1 (fr) * 1991-12-03 1995-05-05 Nicole Bru Composes presentant une liaison amide phosphorique ou une liaison phosphate d'enol pour leur application en tant que substance therapeutiquement active.
DE19603053A1 (de) * 1996-01-29 1997-07-31 Bayer Ag Verfahren zur Herstellung von Polymeren mit wiederkehrenden Succinyl-Einheiten
GB9624188D0 (en) 1996-11-21 1997-01-08 Itc Research Limited Pharmaceutical formulations
CN101511376A (zh) * 2006-09-28 2009-08-19 兴和株式会社 循环器官用药
TW200824676A (en) * 2006-10-24 2008-06-16 Kowa Co Cardiovascular drug

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1083911A (en) * 1964-01-13 1967-09-20 Chugai Pharmaceutical Co Ltd Adenosine triphosphate salts of l-ornithine and process for preparing the same
FR3246M (fr) * 1964-02-06 1965-04-12 Pharmacodynamie Et Metabolisme Médicaments a base d'acide phospho-énol-pyruvique.
DE1939008A1 (de) * 1969-07-31 1971-02-11 Zander Dr Helmut Arzneimittelkombination zur Behandlung von Mangeldurchblutungen des Gehirns
US4216211A (en) * 1977-10-31 1980-08-05 The Procter & Gamble Company Therapeutic composition

Also Published As

Publication number Publication date
EP0085033A1 (en) 1983-08-03
FI833320A0 (fi) 1983-09-16
JPS58502208A (ja) 1983-12-22
ZA83130B (en) 1983-10-26
EP0098853A1 (en) 1984-01-25
NO833257L (no) 1983-09-12
WO1983002391A1 (en) 1983-07-21
FI833320A (fi) 1983-09-16
DK421283A (da) 1983-09-15
DK421283D0 (da) 1983-09-15

Similar Documents

Publication Publication Date Title
DE3775527D1 (de) 1,5-diphenylpyrazol-3-carbonsaeurederivate zum schuetzen von kulturpflanzen.
IT8722790A0 (it) Composti farmacologicamente attivi, procedimenti per la loro preparazione e composizioni che li contengono.
ES2061609T3 (es) 2',3'-dideoxi-2'-fluoro-nucleosidos.
SE8200252L (sv) Farmaceutisk komposition
IT8547877A1 (it) Alfa-amminoacidi la loro preparazione e le composizioni farmaceutiche che li contengono
DK323981A (da) 4,5-diaryl-alfa-polyfluoralkyl-1h-imidazol-2-methanaminer eller syreadditionssalte deraf deres fremstilling og anvendelse som antiinflammatoriske midler
EP0153152A3 (en) (2-oxo-1,2,3,5-tetrahydroimidazo-/2,1-b/quinnazolinyl)-oxyalkylamides, their preparation, compositions containing them and their use in making medicaments
IT8323396A0 (it) Antimuscarinica. composizione farmaceutica adattivita' sistemica anticolinesterasica, agonista-colinergica ed
NO803592L (no) 4,5-umettede prostansyre-derivater.
ZA858195B (en) 1,2,4-triazolo-carbamates and the acid addition salts thereof,processes for preparing them and pharmaceutical compositions
IT8319958A0 (it) Composizioni farmaceutiche adattivita' antineoplastica.
DE3873167D1 (de) Thiazolidin-4-on-derivate und deren saeure-additionssalze.
TR20593A (tr) Biyosit olarak aktif 1,2,3-triazolkarboksilik asit amitleri,bunlarin imaline mahsus bir usul ve kullanilislari
SE8306225D0 (sv) 2-piperazinyl-quinazoline derivatives, their production and pharmaceutical compositions containing them
NO883520D0 (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
ZA793720B (en) Substituted 2-phenylamino-imidazoline-(2)derivatives,acid addition salts thereof,processes for their preparation,and pharmaceutical compositions thereof
NL7804509A (nl) Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan.
IT7920094A0 (it) Octaidro-indolo [2,3-a] chinolizine 1,1 disostituite, procedimento per la loro preparazione e composizioni che le contengono.
NO880088D0 (no) 2,1-benzotiazepin-2,2-dioksyd-5-karboksylsyrederivater.
DK167182A (da) 5,6-o-isoalkylidenascorbinsyrederivater
SU839802A1 (ru) Горочна рельсова цепь
JPS5770861A (en) N,n'-bis(5-oxo-1-methyl-pyrrolidine-2-yl-acetic acid)-hydrazide, manufacture and medicinal composition
ZA793604B (en) Substituted 2-phenylamino-imidazoline-(2)derivatives,acid addition salts thereof,processes for their preparation,and pharmaceutical compositions thereof
DK453485A (da) 1,2,3,4,6,7,12,1rb-octahydroindolo-(2,3-a)quinolizin-1-yl-alkancarboxylsyreamider og farmaceutisk anvendelige syreadditionssalte deraf,deres fremstilling og anvendelse
FR2470111B1 (fr) Derives de la decaprenylamine, leurs sels acides d'addition et composition pharmaceutique utilisant ces produits

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8200252-8